Skip to main content
Figure 2 | Journal of Translational Medicine

Figure 2

From: Impacts of ezetimibe on PCSK9 in rats: study on the expression in different organs and the potential mechanisms

Figure 2

The expression of PCSK9, LDLR, SREBP2 and HNF-1α mRNA analyzed by real-time PCR in liver, intestine and kidney respectively. After ezetimibe treatment for 3 days, the mRNA expression of PCSK9 (A), LDLR (B), and SREBP2 (C) increased significantly in all organs compared with control group, while the expression of HNF-1α mRNA increased markedly only in liver (D). Data are the mean ± SD. *p < 0.05, **p < 0.01, ***p < 0.001, compared with control group.

Back to article page